171 related articles for article (PubMed ID: 20063175)
1. Phase II trial of intratumoral BCNU injection and radiotherapy on untreated adult malignant glioma.
Jenkinson MD; Smith TS; Haylock B; Husband D; Shenoy A; Vinjamuri S; Walker C; Pietronigro D; Warnke PC
J Neurooncol; 2010 Aug; 99(1):103-13. PubMed ID: 20063175
[TBL] [Abstract][Full Text] [Related]
2. NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients.
Ali AN; Zhang P; Yung WKA; Chen Y; Movsas B; Urtasun RC; Jones CU; Choi KN; Michalski JM; Fischbach AJ; Markoe AM; Schultz CJ; Penas-Prado M; Garg MK; Hartford AC; Kim HE; Won M; Curran WJ
J Neurooncol; 2018 Mar; 137(1):39-47. PubMed ID: 29404979
[TBL] [Abstract][Full Text] [Related]
3. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic injection of DTI-015 into recurrent malignant gliomas: phase I/II trial.
Hassenbusch SJ; Nardone EM; Levin VA; Leeds N; Pietronigro D
Neoplasia; 2003; 5(1):9-16. PubMed ID: 12659665
[TBL] [Abstract][Full Text] [Related]
5. Imaging response in malignant glioma, RTOG 90-06.
Lustig RA; Seiferheld W; Berkey B; Yung AW; Scarantino C; Movsas B; Jones CU; Simpson JR; Fishbach J; Curran WJ
Am J Clin Oncol; 2007 Feb; 30(1):32-7. PubMed ID: 17278892
[TBL] [Abstract][Full Text] [Related]
6. The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: phase I trial.
Brem H; Ewend MG; Piantadosi S; Greenhoot J; Burger PC; Sisti M
J Neurooncol; 1995 Nov; 26(2):111-23. PubMed ID: 8787853
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral injection of BCNU in ethanol (DTI-015) results in enhanced delivery to tumor--a pharmacokinetic study.
Hamstra DA; Moffat BA; Hall DE; Young JM; Desmond TJ; Carter J; Pietronigro D; Frey KA; Rehemtulla A; Ross BD
J Neurooncol; 2005 Jul; 73(3):225-38. PubMed ID: 15980973
[TBL] [Abstract][Full Text] [Related]
8. Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02.
Werner-Wasik M; Scott CB; Nelson DF; Gaspar LE; Murray KJ; Fischbach JA; Nelson JS; Weinstein AS; Curran WJ
Cancer; 1996 Apr; 77(8):1535-43. PubMed ID: 8608540
[TBL] [Abstract][Full Text] [Related]
9. An analysis of radiotherapy data from the CNS cancer consortium's randomized prospective trial comparing AZQ to BCNU in the treatment of patients with primary malignant brain tumors. The CNS cancer consortium.
Halperin EC; Gaspar L; Imperato J; Salter M; Herndon J; Dowling S
Am J Clin Oncol; 1993 Aug; 16(4):277-83. PubMed ID: 8392285
[TBL] [Abstract][Full Text] [Related]
10. Treatment of recurrent malignant glioma with BCNU-fluosol and oxygen inhalation. A phase I-II study.
Hochberg F; Prados M; Russell C; Weissman D; Evans R; Cook P; Burton G; Eisenberg PD; Valenzuela R; Verkh L
J Neurooncol; 1997 Mar; 32(1):45-55. PubMed ID: 9049862
[TBL] [Abstract][Full Text] [Related]
11. Safety evaluation of high-dose BCNU-loaded biodegradable implants in Chinese patients with recurrent malignant gliomas.
Sai K; Zhong MG; Wang J; Chen YS; Mou YG; Ke C; Zhang XH; Yang QY; Lin FH; Guo CC; Chen ZH; Zeng J; Lv YC; Li X; Gao WC; Chen ZP
J Neurol Sci; 2014 Aug; 343(1-2):60-5. PubMed ID: 24874252
[TBL] [Abstract][Full Text] [Related]
12. Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors.
Prados MD; Larson DA; Lamborn K; McDermott MW; Sneed PK; Wara WM; Chang SM; Mack EE; Krouwer HG; Chandler KL; Warnick RE; Davis RL; Rabbitt JE; Malec M; Levin VA; Gutin PH; Phillips TL; Wilson CB
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):57-63. PubMed ID: 9422558
[TBL] [Abstract][Full Text] [Related]
13. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
[TBL] [Abstract][Full Text] [Related]
14. Randomized comparison of diaziquone and carmustine in the treatment of adults with anaplastic glioma.
Schold SC; Herndon JE; Burger PC; Halperin EC; Vick NA; Cairncross JG; Macdonald DR; Dropcho EJ; Morawetz R; Bigner DD
J Clin Oncol; 1993 Jan; 11(1):77-83. PubMed ID: 8418246
[TBL] [Abstract][Full Text] [Related]
15. A multicenter phase I/II study of the BCNU implant (Gliadel(®) Wafer) for Japanese patients with malignant gliomas.
Aoki T; Nishikawa R; Sugiyama K; Nonoguchi N; Kawabata N; Mishima K; Adachi J; Kurisu K; Yamasaki F; Tominaga T; Kumabe T; Ueki K; Higuchi F; Yamamoto T; Ishikawa E; Takeshima H; Yamashita S; Arita K; Hirano H; Yamada S; Matsutani M;
Neurol Med Chir (Tokyo); 2014; 54(4):290-301. PubMed ID: 24739422
[TBL] [Abstract][Full Text] [Related]
16. Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma: implications for patient management.
Kleinberg LR; Weingart J; Burger P; Carson K; Grossman SA; Li K; Olivi A; Wharam MD; Brem H
Cancer Invest; 2004; 22(1):1-9. PubMed ID: 15069758
[TBL] [Abstract][Full Text] [Related]
17. Accelerated hyperfractionated radiation therapy for malignant glioma. A phase II study.
Jeremic B; Grujicic D; Antunovic V; Djuric L; Shibamoto Y
Am J Clin Oncol; 1995 Oct; 18(5):449-53. PubMed ID: 7572767
[TBL] [Abstract][Full Text] [Related]
18. Intracarotid chemotherapy with 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) in 5% dextrose in water in the treatment of malignant glioma.
Johnson DW; Parkinson D; Wolpert SM; Kasdon DL; Kwan ES; Laucella M; Anderson ML
Neurosurgery; 1987 Apr; 20(4):577-83. PubMed ID: 3587550
[TBL] [Abstract][Full Text] [Related]
19. Use of 201Tl SPECT imaging to assess the response to therapy in patients with high grade gliomas.
Vallejos V; Balaña C; Fraile M; Roussos Y; Capellades J; Cuadras P; Ballester R; Ley A; Arellano A; Rosell R
J Neurooncol; 2002 Aug; 59(1):81-90. PubMed ID: 12222842
[TBL] [Abstract][Full Text] [Related]
20. Incorporating BCNU wafers into malignant glioma treatment: European case studies.
Balossier A; Dörner L; Emery E; Heese O; Mehdorn HM; Menei P; Singh J
Clin Drug Investig; 2010; 30(3):195-204. PubMed ID: 20155992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
